MGC Pharmaceuticals Price Prediction

MGCLFDelisted Stock  USD 0.21  0.00  0.00%   
As of 24th of November 2024 the value of rsi of MGC Pharmaceuticals' share price is below 20 . This indicates that the otc stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

11

 
Oversold
 
Overbought
MGC Pharmaceuticals stock price prediction is an act of determining the future value of MGC Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of MGC Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of MGC Pharmaceuticals and does not consider all of the tangible or intangible factors available from MGC Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with MGC Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of MGC Pharmaceuticals based on different types of headlines from major news networks to social media. Using MGC Pharmaceuticals hype-based prediction, you can estimate the value of MGC Pharmaceuticals from the perspective of MGC Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in MGC Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in MGC Pharmaceuticals to buy its otc stock at a price that has no basis in reality. In that case, they are not buying MGC because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

MGC Pharmaceuticals after-hype prediction price

    
  USD 0.21  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Intrinsic
Valuation
LowRealHigh
0.190.190.23
Details
Naive
Forecast
LowNextHigh
0.210.210.21
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.210.210.21
Details

MGC Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of MGC Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MGC Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of MGC Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

MGC Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting MGC Pharmaceuticals' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MGC Pharmaceuticals' historical news coverage. MGC Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.21 and 0.21, respectively. We have considered MGC Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.21
0.21
After-hype Price
0.21
Upside
MGC Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of MGC Pharmaceuticals is based on 3 months time horizon.

MGC Pharmaceuticals OTC Stock Price Prediction Analysis

Have you ever been surprised when a price of a OTC Stock such as MGC Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MGC Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MGC Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
1 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.21
0.21
0.00 
0.00  
Notes

MGC Pharmaceuticals Hype Timeline

MGC Pharmaceuticals is now traded for 0.21. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. MGC is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on MGC Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.21. The company recorded a loss per share of 0.01. MGC Pharmaceuticals had not issued any dividends in recent years. Assuming the 90 days horizon the next expected press release will be uncertain.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

MGC Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to MGC Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict MGC Pharmaceuticals' future price movements. Getting to know how MGC Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MGC Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
CBDNFCBD Global Sciences 0.00 0 per month 0.00 (0.06) 14.75 (13.33) 47.67 
CBDYTarget Group 0.00 0 per month 12.10  0.09  38.10 (25.00) 83.33 
AQSZFAequus Pharmaceuticals 0.04 22 per month 0.00 (0.15) 2.22 (10.64) 45.35 
FLHLFFilament Health Corp 0.00 0 per month 13.07  0.05  27.08 (24.77) 91.17 
SKYISky Century Investment 0.00 0 per month 14.21  0.12  41.67 (40.00) 212.75 
LVTTFLevitee Labs 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
SFWJSoftware Effective Solutions 0.00 0 per month 13.70  0.05  39.13 (27.27) 174.89 
BCBCFThe BC Bud 0.00 0 per month 9.94  0.14  10.89 (13.07) 425.33 
AXRXAmexdrug 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ANTCFAion Therapeutic 0.00 0 per month 0.00  0.15  76.99 (48.53) 451.80 
APNHFAspen Pharmacare Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ATHJFAntisense Therapeutics Limited 0.00 0 per month 0.00  0.11  0.00  0.00  330.62 

MGC Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine MGC price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MGC using various technical indicators. When you analyze MGC charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About MGC Pharmaceuticals Predictive Indicators

The successful prediction of MGC Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as MGC Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of MGC Pharmaceuticals based on analysis of MGC Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to MGC Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to MGC Pharmaceuticals's related companies.

Story Coverage note for MGC Pharmaceuticals

The number of cover stories for MGC Pharmaceuticals depends on current market conditions and MGC Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MGC Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MGC Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

MGC Pharmaceuticals Short Properties

MGC Pharmaceuticals' future price predictability will typically decrease when MGC Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MGC Pharmaceuticals often depends not only on the future outlook of the potential MGC Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MGC Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.6 B
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Consideration for investing in MGC OTC Stock

If you are still planning to invest in MGC Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MGC Pharmaceuticals' history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments